ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1142

Implementation of an Evidence-based Transition Clinic in a Pediatric Rheumatology Academic Institution

Rebecca Overbury1, Tracy Frech2, John Bohnsack3, CJ Inman1, Sara Stern1, Karen James1, Erin Treemarcki4 and Aimee Hersh4, 1University of Utah and Primary Children's Hospital, Salt Lake City, UT, 2University of Utah and Salt Lake Veterans Affair Medical Center, Salt Lake City, UT, 3University of Utah and Primary Children's Hospital, Cincinnati, OH, 4University of Utah and Primary Children's Hospital, Salt Lake City

Meeting: ACR Convergence 2020

Keywords: education, patient, Health Services Research, Patient reported outcomes, Pediatric rheumatology, registry

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 8, 2020

Title: Patient Outcomes, Preferences, & Attitudes Poster II: Miscellaneous Rheumatic Diseases

Session Type: Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Transition from pediatric to adult rheumatology care is more likely to be successful if a transition program is in place. Previously successful interventions to improve transition outcomes have included integrating an adult subspecialist in the pediatric clinic setting. We hypothesize that we will improve transition outcomes by implementing a transition clinic which includes an adult rheumatologist providing care within a pediatric rheumatology clinic.

Methods: We initiated a weekly transition clinic in November 2018 called ACCORD (Adult Center for Childhood Onset Rheumatic Disease). This clinic is staffed by 1 adult rheumatologist (board certified in internal medicine and pediatrics), 2 pediatric nurses, and 2 research coordinators. Patients can be seen if they are ≥ 16 years old with known rheumatic disease or suspicion for rheumatic disease. All patients (and legal guardians) receive education and monitoring of transition readiness. We provide transition readiness education and feedback in 6 discrete modules adapted from Got Transition Tm (Table 1). All patients (and legal guardians) complete patient reported outcome measures (PRO’s). We maximize continuity of care in several ways: our adult rheumatologist meets pediatric patients who anticipate transfer to the transition clinic, she manages all transition clinic visits and education, and when possible she migrates care to our institution’s associated adult rheumatology clinic.  Demographics, PRO’s, transition readiness measures, and clinical outcomes are collected in a prospective longitudinal registry.

Results: 35 patients have now participated in our transition clinic and been enrolled in our registry (Table 2). 9 patients (25.7%) thus far have decided, with the adult rheumatologist, to attempt to transition to an adult provider. 1 of the 9 transitioned to a provider other than the adult rheumatologist. 8 of the 9 transitioned to the adult clinic of the adult rheumatologist. Of the 9, all have had at least one follow up appointment with their new adult provider. 5 of the 9 (55.6%) had gaps of ≤ 4 months between their last pediatric rheumatology clinic visit and their first adult rheumatology clinic visit. The longest gap between visits was 8 months. Of the 4 in whom subsequent follow up appointments have been indicated with their adult rheumatologist, all 4 have successfully kept these appointments on time. 1 of 35 (2.9%) has been lost to follow up (gap > 3 months past scheduled/recommended visit without subsequent successful contact).

Conclusion: Our unique transition clinic is in its early stages of development. However, this research shows that our interventions including a dedicated transition education and planning in the clinical setting as well as the integration of a Med/Peds trained adult rheumatologist can improve the chance of a successful clinical transition from pediatric to adult sub-specialty care.


Disclosure: R. Overbury, None; T. Frech, None; J. Bohnsack, AbbVie, 2, Bristol-Myers Squibb, 2, Janssen, 2, Pfizer Inc, 2, Roche, 2; C. Inman, None; S. Stern, None; K. James, None; E. Treemarcki, None; A. Hersh, None.

To cite this abstract in AMA style:

Overbury R, Frech T, Bohnsack J, Inman C, Stern S, James K, Treemarcki E, Hersh A. Implementation of an Evidence-based Transition Clinic in a Pediatric Rheumatology Academic Institution [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/implementation-of-an-evidence-based-transition-clinic-in-a-pediatric-rheumatology-academic-institution-2/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/implementation-of-an-evidence-based-transition-clinic-in-a-pediatric-rheumatology-academic-institution-2/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology